Memorial Day! 45% Off Premium Subscription Claim Offer ⏰ 0d 00h 00m 00s
AI Analysis AI Analysis of ABUS
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Green day on Thursday for Arbutus Biopharma Corporation
(Updated on May 22, 2025)

Sell candidate since May 13, 2025 Gain 0.94%

The Arbutus Biopharma Corporation stock price gained 1.58% on the last trading day (Thursday, 22nd May 2025), rising from $3.17 to $3.22. During the last trading day the stock fluctuated 4.02% from a day low at $3.11 to a day high of $3.24. The price has fallen in 6 of the last 10 days and is down by -2.42% for this period. Volume fell on the last day by -330 thousand shares and in total, 765 thousand shares were bought and sold for approximately $2.46 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.09% during the next 3 months and, with a 90% probability hold a price between $2.74 and $3.47 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

ABUS Signals & Forecast

There are mixed signals in the stock today. The Arbutus Biopharma Corporation stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.25. On a fall, the stock will find some support from the short-term average at $3.16. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Friday, May 16, 2025, and so far it has risen 4.55%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Arbutus Biopharma Corporation stock

Arbutus Biopharma Corporation finds support from accumulated volume at $3.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.125 between high and low, or 4.02%. For the last week, the stock has had daily average volatility of 3.92%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ABUS) For The Upcoming Trading Day Of Friday 23rd

For the upcoming trading day on Friday, 23rd we expect Arbutus Biopharma Corporation to open at $3.19, and during the day (based on 14 day Average True Range), to move between $3.06 and $3.38, which gives a possible trading interval of +/-$0.163 (+/-5.06%) up or down from last closing price. If Arbutus Biopharma Corporation takes out the full calculated possible swing range there will be an estimated 10.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.19 (0.93%) than the resistance at $3.37 (4.66%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Arbutus Biopharma Corporation stock A Buy?

Arbutus Biopharma Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.668 Sell Candidate Unchanged

Want to trade but not sure how? Our step-by-step guide can help. Skip the guide? Open account with our trusted broker

Predicted Fair Opening Price

Predicted fair opening price on May 23, 2025 - $3.19 ( 0.98%).

ABUS Performance

Trading levels for ABUS

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis Powered by GPT-4o*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.31 2.90%
R2 3.27 1.42%
R1 3.24 0.499%
Price 3.22
S1 3.14 -2.47%
S2 3.11 -3.38%
S3 3.06 -4.87%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.51 9.01%
R2 3.45 7.14%
R1 3.37 4.66%
Price 3.22
S1 3.19 -0.93%
S2 3.17 -1.55%
S3 3.12 -3.11%

FAQ

What is the symbol for Arbutus Biopharma Corporation Stock and on which exchange is it traded?
The symbol for Arbutus Biopharma Corporation is ABUS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Arbutus Biopharma Corporation Stock?
Arbutus Biopharma Corporation holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Arbutus Biopharma Corporation Stock?
Arbutus Biopharma Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Arbutus Biopharma Corporation Stock.

What's the current price of Arbutus Biopharma Corporation Stock?
As of the end of day on the May 22, 2025, the price of an Arbutus Biopharma Corporation (ABUS) share was $3.22.

What is the 52-week high and low for Arbutus Biopharma Corporation Stock?
The 52-week high for Arbutus Biopharma Corporation Stock is $4.72 and the 52-week low is $2.71.

What is the market capitalization of Arbutus Biopharma Corporation Stock?
As of the May 22, 2025, the market capitalization of Arbutus Biopharma Corporation is 607.141M.

When is the next earnings date for Arbutus Biopharma Corporation?
The upcoming earnings date for Arbutus Biopharma Corporation is Aug 07, 2025.
Click to get the best stock tips daily for free!
ABOUT ARBUTUS BIOPHARMA CORPORATION
Arbutus Biopharma
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ...
GOLDEN STAR
Ticker Change Signal Date
UAA
$5.84
11.64% May 09
IIPR
$54.61
1.70% May 09
HBM
$7.41
14.44% May 05
PODD
$257.01
24.90% May 02
GT
$9.14
21.77% Mar 21

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE